

Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Lead Product(s) : Tirofiban Hydrochloride Monohydrate
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Grand Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Study on Tirofiban With Aspirin in the Treatment of Acute Penetrating Artery Territory Infarction
Details : Tirofiban HCl is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Branch Atheromatous Disease.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 05, 2022
Lead Product(s) : Tirofiban Hydrochloride Monohydrate
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Grand Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Tirofiban Hydrochloride Monohydrate,Tirofiban,Aspirin,Clopidogrel
Therapeutic Area : Hematology
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Notably, a non-randomized, case-controlled, investigator sponsored proof of concept study evaluating AGGRASTAT® in combination with standard of care in patients with severe COVID-19 and hypercoagulability found that enhanced platelet inhibition improves...
Product Name : Aggrastat
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 24, 2020
Lead Product(s) : Tirofiban Hydrochloride Monohydrate,Tirofiban,Aspirin,Clopidogrel
Therapeutic Area : Hematology
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Tirofiban Hydrochloride Monohydrate,Tirofiban,Prasugrel
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Medicure Announces Top Line Data from FABOLUS-FASTER Trial With AGGRASTAT
Details : The FABOLUS-FASTER trial was designed to assess different regimens of intravenous platelet inhibitors, notably AGGRASTAT® (tirofiban hydrochloride) injection (an IV GP IIb/IIIa inhibitor) and cangrelor (an IV P2Y12 inhibitor) in the early phase of prima...
Product Name : Aggrastat
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 15, 2020
Lead Product(s) : Tirofiban Hydrochloride Monohydrate,Tirofiban,Prasugrel
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Tirofiban Hydrochloride Monohydrate
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : SCRI Development Innovations, LLC
Deal Size : Inapplicable
Deal Type : Inapplicable
Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary Intervention
Details : Aggrastat (Tirofiban HCl) is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Myocardial Infarction.
Product Name : Aggrastat
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 22, 2010
Lead Product(s) : Tirofiban Hydrochloride Monohydrate
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : SCRI Development Innovations, LLC
Deal Size : Inapplicable
Deal Type : Inapplicable
